Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Fatigue | D005221 | — | R53.83 | — | — | 1 | — | 1 | 2 |
Chronic fatigue syndrome | D015673 | EFO_0004540 | G93.31 | — | — | 1 | — | 1 | 2 |
Syndrome | D013577 | — | — | — | — | 1 | — | 1 | 2 |
Myalgia | D063806 | — | M79.1 | — | — | 1 | — | — | 1 |
Encephalomyelitis | D004679 | EFO_0001423 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma | D000230 | — | — | 1 | 2 | — | — | — | 2 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | 2 | — | — | — | 2 |
Hiv seropositivity | D006679 | — | — | — | 2 | — | — | — | 2 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | 2 | — | — | — | 2 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 2 | 2 | — | — | — | 2 |
Ovarian epithelial carcinoma | D000077216 | — | — | 2 | 2 | — | — | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | — | 1 | — | — | — | 1 |
Human influenza | D007251 | EFO_0007328 | J11.1 | 1 | 1 | — | — | — | 1 |
Disease | D004194 | EFO_0000408 | R69 | — | 1 | — | — | — | 1 |
Post-acute covid-19 syndrome | D000094024 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | — | — | — | 1 |
Triple negative breast neoplasms | D064726 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Rintatolimod |
INN | rintatolimod |
Description | Rintatolimod, sold under the tradename Ampligen, is a medication intended for treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). There is some evidence it may improve some ME/CFS symptoms.
|
Classification | Oligonucleotide |
Drug class | immunomodulators: immunomodulators, toll-like receptor agonists |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 38640-92-5 |
RxCUI | — |
ChEMBL ID | CHEMBL2107862 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 94325AJ25N (ChemIDplus, GSRS) |